Early-stage gastric and gastroesophageal junction cancer: Is there a survival benefit to neoadjuvant therapy? Waller GC, Patel DJ, Baker MS. Surgery 2022;172:1753-1758.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Waller GC, Patel DJ, Baker MS. Early-stage gastric and gastroesophageal junction cancer: Is there a survival benefit to neoadjuvant therapy? Surgery 2022;172:1753-1758.
PMID: 36155146